Back to results
US 2003/0166576 A1Published application
Urokinase inhibitors
AssigneeCuracyte AG
InventorsJorg Stürzebecher, Torsten Steinmetzer, Andrea Schweinitz
Life of this patent
Estimating the term…
Abstract
The invention relates to a highly active, highly specific urokinase inhibitor which is suitable for therapeutic applications and can be synthesized in an extremely simple manner. Surprisingly, it was found that amidino benzylamine derivatives, especially 4-amidino-benzylamine, with two bonded amino acids represent a new group of highly active and very selective uPA inhibitors. The urokinase inhibitors can be used in medical applications, e.g. in the treatment of malign tumors such as in cases of metastatic spread.
Claims5
A urokinase inhibitor of the formula I:
- 1
- in which the substituent Y can be present in the 3 position or 4 position and is an amidino group
- 2
- in which R5 is an H, an OH or a carbonyl radical —CO—R or oxycarbonyl radical —COO—R, where R can be a branched or unbranched alkyl having 1-16 C atoms, a substituted or unsubstituted aryl or heteroaryl radical or a substituted or unsubstituted aralkyl or heteroaralkyl radical,
- X is a CH group or N,
- R1 is H or a branched or unbranched alkyl having 1-8 C atoms or a (CH2)n—OH in which n=1-5,
- R2 is an H or a branched or unbranched alkyl having 1-8 C atoms,
- R3 is a (CH2)n—OH in which n=1-5 or is a branched or unbranched alkyl having 1-8 C atoms or is present in prodrug form and is a (CH2)n—OX in which n=1-5, where X can be an alkyl, aralkyl or aralkylcarbonyl radical or a corresponding oxycarbonyl radical,
- and R4 is a sulfonyl radical —SO2—R, a carbonyl radical —CO—R, an oxycarbonyl radical —COO—R or an H, where
- R is a branched or unbranched alkyl having 1-16 C atoms, a substituted or unsubstituted aryl or heteroaryl radical, a substituted or unsubstituted aralkyl or heteroaralkyl radical or an adamantyl radical or a camphor radical.
7 more elements
Dependencies are inferred from the claim text.